We have established a triple immunostaining protocol for the simultaneous investigation of estrogen receptor (ER), keratins (K) 8/18/19, and CD45 expression on our CTC model system (blood of healthy volunteers spiked with breast cancer cell line cells) with the possibility of further single cell ESR1 gene mutation analysis. Here, PTPRC is linked to breast carcinoma.